Wan Sun
Impact in
-
- Chronic Lymphocytic Leukemia Research
- Inflammatory Bowel Disease
-
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
Papers in
-
- Advanced Breast Cancer Therapies 9
- Oncology 9
- HER2/EGFR in Cancer Research 3
- Cancer-related Molecular Pathways 3
- Co-authors
- Diane Wang (5 shared papers)Richard S. Finn (2 shared papers)Anna Plotka (2 shared papers)Melissa O’Gorman (2 shared papers)Nicholas C. Turner (3 shared papers)Karen J. Klamerus (1 shared paper)Sylvester Pawlak (1 shared paper)Maha Kosa (1 shared paper)
- Journals
- Journal of Crohn s and Colitis (3 papers)The Journal of Clinical Pharmacology (3 papers)BMC Plant Biology (2 papers)Cancer Research (2 papers)Journal of Pharmacokinetics and Pharmacodynamics (1 paper)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Wan Sun
23 papers receiving 322 citations
Peers
Comparison fields: 5 of 63
- Genetics 71
- Oncology 149
- Pulmonary and Respiratory Medicine 145
- Cancer Research 39
- Dermatology 15
Countries citing papers authored by Wan Sun
This map shows the geographic impact of Wan Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan Sun more than expected).
Fields of papers citing papers by Wan Sun
This network shows the impact of papers produced by Wan Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan Sun. The network helps show where Wan Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Wan Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 59 | |
| 2 | 2017 | 58 | |
| 3 | 2020 | 36 | |
| 4 | 2017 | 36 | |
| 5 | 2024 | 32 | |
| 6 | Influences of neoadjuvant chemotherapy on clinical indicators, prognosis and neutrophil/lymphocyte ratio of stage IB2-IIB cervical cancer. | 2021 | 12 |
| 7 | 2021 | 11 | |
| 8 | 2013 | 11 | |
| 9 | 2021 | 9 | |
| 10 | 2019 | 9 | |
| 11 | 2020 | 9 | |
| 12 | 2017 | 8 | |
| 13 | 2020 | 7 | |
| 14 | 2017 | 5 | |
| 15 | 2017 | 4 | |
| 16 | 2019 | 4 | |
| 17 | 2014 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2021 | 2 | |
| 20 | 2025 | 2 |
About Wan Sun
Wan Sun is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Genetics and Molecular Biology, having authored 24 papers that have together received 322 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (9 papers), Chronic Lymphocytic Leukemia Research (4 papers), Biosimilars and Bioanalytical Methods (4 papers), HER2/EGFR in Cancer Research (3 papers), Pharmaceutical studies and practices (3 papers), Inflammatory Bowel Disease (3 papers), Cancer-related Molecular Pathways (3 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Genetics (71 citations), Oncology (149 citations), Pulmonary and Respiratory Medicine (145 citations), Cancer Research (39 citations) and Dermatology (15 citations). Wan Sun has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Diane Wang, Richard S. Finn, Anna Plotka, Melissa O’Gorman, Nicholas C. Turner, Karen J. Klamerus, Sylvester Pawlak, Maha Kosa, Geoffrey I. Shapiro and Ana Ruiz-Garcı́a. Their work appears in journals such as Journal of Crohn s and Colitis, The Journal of Clinical Pharmacology, BMC Plant Biology, Cancer Research and Journal of Pharmacokinetics and Pharmacodynamics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.